2025. Skin Clearance and Itch Relief in Black or African American Patients with Moderate-to-Severe Atopic Dermatitis Treated with Upadacitinib: 140-Week Outcomes from Integrated Phase 3 Measure Up 1 and 2 Studies. SKIN The Journal of Cutaneous Medicine. 9, 6 (Nov. 2025), s615. DOI:https://doi.org/10.25251/9qs79351.